Furthermore, a recent hypothesis also suggests that synaptic dysfunction in Alzheimer’s disease is triggered by impairment of APP metabolism which further progresses via tau pathology (Gulisano et al., 2018; Kametani and Hasegawa, 2018; Schreurs et al., 2018). The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.